CREB1 and Alzheimer disease: An Alzheimer’s disease (AD) study also demonstrated that FXR overexpression interacts with CREB, decreasing CREB and BDNF protein levels, increasing amyloid-β (Aβ) deposition, and aggravating Aβ-induced neuronal apoptosis.